Draw attention to the teratogenic effect of DMD in MS treatment

<p>More than 2.3 million people are affected by Multiple Sclerosis (MS) worldwide. Since the 1990s, disease modifying drug (DMD) has been developing increasingly. With more and more clinical applications, more and more attention has been paid to the adverse effects of DMD in the treatment of M...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Shi-Fang Hou (Author), Yin Jian (Author), Li-Yan Qiao (Author), Zun-Bao Li (Author), Kai Feng (Author), Xian-Hao Xu (Author)
Hōputu: Pukapuka
I whakaputaina: Journal of Clinical Research and Ophthalmology - Peertechz Publications, 2020-09-18.
Ngā marau:
Urunga tuihono:Connect to this object online.
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2455-1414_000081
042 |a dc 
100 1 0 |a Shi-Fang Hou  |e author 
700 1 0 |a  Yin Jian  |e author 
700 1 0 |a  Li-Yan Qiao  |e author 
700 1 0 |a  Zun-Bao Li  |e author 
700 1 0 |a  Kai Feng  |e author 
700 1 0 |a Xian-Hao Xu  |e author 
245 0 0 |a Draw attention to the teratogenic effect of DMD in MS treatment 
260 |b Journal of Clinical Research and Ophthalmology - Peertechz Publications,   |c 2020-09-18. 
520 |a <p>More than 2.3 million people are affected by Multiple Sclerosis (MS) worldwide. Since the 1990s, disease modifying drug (DMD) has been developing increasingly. With more and more clinical applications, more and more attention has been paid to the adverse effects of DMD in the treatment of MS. DMD selection for patients with MS during pregnancy is one of the most important topics for neuroimmunologists and obstetrics. This comment is mainly based on our published and forthcoming data. </p><p><br></p> 
540 |a Copyright © Shi-Fang Hou et al. 
546 |a en 
655 7 |a Mini Review  |2 local 
856 4 1 |u https://doi.org/10.17352/2455-1414.000081  |z Connect to this object online.